An announcement from Mineralys Therapeutics, Inc. ( ($MLYS) ) is now available. On January 6, 2026, Mineralys Therapeutics provided a corporate ...

Legacy firms can’t advise AI reinvention without reinventing themselves. Real change means shifting from labor-based models ...

Allergen Alert says it is transforming our relationship with food, making it more transparent, more responsible, more ...

Web3 SaaS platform Roundtable signed a 10-year exclusive agreement to operate The Hockey News’ media network, commerce ...

Amanpal Dhupar, Head of Retail at Tredence is an experienced retail analytics and AI leader with over a decade of expertise ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease ...

For decades, books have been seen primarily as finished products. An author writes a manuscript, a publisher prints it, and ...

Coalfire, an industry-leading cybersecurity services and solutions company backed by funds advised by Apax Partners LLP ("Apax"), today announced the appointment of Brad Little as its new chief ...

By involving children as active participants in their own anti-bullying efforts, schools can foster empathy, critical ...

On Wednesday, AstroNova (NASDAQ:ALOT) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below.

The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...

The collaboration leverages BostonGene's foundation model for tumor and immune biology to deliver predictive insights on patient-level safety and efficacy outcomes in early clinical trials.